市場調查報告書

甲狀腺癌治療藥的全球市場:2020年

Thyroid Cancer Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 918143
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
甲狀腺癌治療藥的全球市場:2020年 Thyroid Cancer Drugs Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球甲狀腺癌治療藥市場的相關調查,提供市場趨勢及策略,市場成長及阻礙因素,各藥物類型·終端用戶·類型·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模及成長

  • 過去的市場
  • 市場預測
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各藥物類型:過去/預測
    • Ipilimumab
    • Cabozantinib(Cabozantinib-S-Malate)
    • Vandetanib
    • 阿霉素鹽酸鹽
    • 甲磺酸Lenvatinib
    • Nivolumab
    • Vandetanib
    • 其他
  • 各終端用戶:過去/預測
    • 醫院
    • 腫瘤科診所
    • 研究機關
    • 其他
  • 各類型:過去/預測
    • 放射性碘切除
    • 甲狀腺刺激素(THS)抑制
    • 化療
    • 多激酶標靶治療
    • 其他

第5章 市場分析:各區各國

  • 市場過去/預測:各地區
  • 市場過去/預測:各國

第6章 亞太地區市場

  • 市場概要
  • 市場過去/預測:各藥物類型
  • 市場過去/預測:各終端用戶
  • 市場過去/預測:各類型

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 競爭情形及企業簡介

  • 競爭情形
  • 企業簡介
    • Mylan Pharmaceuticals Inc.
    • Alara Pharmaceutical Corporation
    • Bristol Myers co.
    • Teva parenteral medicines Inc.
    • Jerome Stevens Pharmaceuticals Inc.

第26章 主要合併及收購

第27章 市場趨勢及策略

第28章 產品平台分析

第29章 市場今後的預測及潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • 商務調查企業
  • 著作權及免責聲明
目錄

Thyroid Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global thyroid cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the thyroid cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Thyroid Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Others 2) By End Users: Hospitals, Oncology Clinics, Research Organizations, Others 3) By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Others

Companies Mentioned: Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Thyroid Cancer Drugs Market Characteristics

3. Thyroid Cancer Drugs Market Size And Growth

  • 3.1. Global Thyroid Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Thyroid Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Thyroid Cancer Drugs Market Segmentation

  • 4.1. Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Ipilimumab
    • Cabozantinib-S-Malate
    • Caprelsa (Vandetanib)
    • Doxorubicin Hydrochloride
    • Lenvatinib Mesylate
    • Nivolumab
    • Vandetanib
    • Others
  • 4.2. Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals
    • Oncology Clinics
    • Research Organizations
    • Others
  • 4.3. Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Radioiodine Ablation
    • Thyroid Stimulating Hormone (THS) Suppression
    • Chemotherapy
    • Targeted Multikinase Therapy
    • Others

5. Thyroid Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Thyroid Cancer Drugs Market

  • 6.1. Asia-Pacific Thyroid Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Thyroid Cancer Drugs Market

  • 7.1. China Thyroid Cancer Drugs Market Overview
  • 7.2. China Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Thyroid Cancer Drugs Market

  • 8.1. India Thyroid Cancer Drugs Market Overview
  • 8.2. India Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Thyroid Cancer Drugs Market

  • 9.1. Japan Thyroid Cancer Drugs Market Overview
  • 9.2. Japan Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Thyroid Cancer Drugs Market

  • 10.1. Australia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Thyroid Cancer Drugs Market

  • 11.1. Indonesia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Thyroid Cancer Drugs Market

  • 12.1. South Korea Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Thyroid Cancer Drugs Market

  • 13.1. Western Europe Thyroid Cancer Drugs Market Overview
  • 13.2. Western Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Thyroid Cancer Drugs Market

  • 14.1. UK Thyroid Cancer Drugs Market Overview
  • 14.2. UK Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Thyroid Cancer Drugs Market

  • 15.1. Germany Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Thyroid Cancer Drugs Market

  • 16.5. France Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Thyroid Cancer Drugs Market

  • 17.1. Eastern Europe Thyroid Cancer Drugs Market Overview
  • 17.2. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Thyroid Cancer Drugs Market

  • 18.1. Russia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Thyroid Cancer Drugs Market

  • 19.1. North America Thyroid Cancer Drugs Market Overview
  • 19.2. North America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Thyroid Cancer Drugs Market

  • 20.1. USA Thyroid Cancer Drugs Market Overview
  • 20.2. USA Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Thyroid Cancer Drugs Market

  • 21.1. South America Thyroid Cancer Drugs Market Overview
  • 21.2. South America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Thyroid Cancer Drugs Market

  • 22.1. Brazil Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Thyroid Cancer Drugs Market

  • 23.1. Middle East Thyroid Cancer Drugs Market Overview
  • 23.2. Middle East Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Thyroid Cancer Drugs Market

  • 24.1. Africa Thyroid Cancer Drugs Market Overview
  • 24.2. Africa Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Thyroid Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Thyroid Cancer Drugs Market Competitive Landscape
  • 25.2. Thyroid Cancer Drugs Market Company Profiles
    • 25.2.1. Mylan Pharmaceuticals Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Alara Pharmaceutical Corporation
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bristol Myers co.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Teva parenteral medicines Inc.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Jerome Stevens Pharmaceuticals Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Thyroid Cancer Drugs Market

27. Thyroid Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer